CoChat

Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload

Open access
Ma, Zhen, Huebsch, Nathaniel, Koo, Sangmo, Mandegar, Mohammad A., Siemons, Brian, Boggess, Steven, Conklin, Bruce R., Grigoropoulos, Costas P., Healy, Kevin E. · 2018 · Nature Biomedical Engineering
Cited by 109

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The integration of in vitro cardiac tissue models, human induced pluripotent stem cells (hiPSCs) and genome-editing tools allows for the enhanced interrogation of physiological phenotypes and recapitulation of disease pathologies. Here, using a cardiac tissue model consisting of filamentous three-dimensional matrices populated with cardiomyocytes derived from healthy wild-type (WT) hiPSCs (WT hiPSC-CMs) or isogenic hiPSCs deficient in the sarcomere protein cardiac myosin-binding protein C (MYBPC3–/– hiPSC-CMs), we show that the WT microtissues adapted to the mechanical environment with increased contraction force commensurate to matrix stiffness, whereas the MYBPC3–/– microtissues exhibited impaired force development kinetics regardless of matrix stiffness and deficient contraction force only when grown on matrices with high fibre stiffness. Under mechanical overload, the MYBPC3–/– microtissues had a higher degree of calcium transient abnormalities, and exhibited an accelerated decay of calcium dynamics as well as calcium desensitization, which accelerated when contracting against stiffer fibres. Our findings suggest that MYBPC3 deficiency and the presence of environmental stresses synergistically lead to contractile deficits in cardiac tissues. Cardiac tissue engineered to enable the modulation of mechanical resistance to tissue contraction facilitates the modelling of genetic pathologies associated with the absence of a thick-filament accessory protein found in striated heart muscle.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41551-018-0280-4

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 46

  1. Carrier, L., Mearini, G., Stathopoulou, K. & Cuello, F. Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology. Gene 573, 188–197 (2015). · DOI · Paper page
  2. Strande, J. L. Haploinsufficiency MYBPC3 mutations: another stress induced cardiomyopathy? Let’s take a look! J. Mol. Cell. Cardiol. 79, 284–286 (2015). · DOI
  3. Eng, G. et al. Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes. Nat. Commun. 7, 10312 (2016). · DOI · Paper page
  4. Conradi, L. et al. Immunobiology of fibrin-based engineered heart tissue. Stem Cells Transl. Med. 4, 625–631 (2015). · DOI
  5. Legant, W. R. et al. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc. Natl Acad. Sci. USA 106, 10097–10102 (2009). · DOI · Paper page
  6. Mathur, A. et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep. 5, 8883 (2015). · DOI · Paper page
  7. Abramson, S. V. et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann. Intern. Med. 116, 888–895 (1992). · DOI · Paper page
  8. Engler, A. J. et al. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J. Cell Sci. 121, 3794–3802 (2008). · DOI · Paper page
  9. Kijlstra, J. D. et al. Integrated analysis of contractile kinetics, force generation, and electrical activity in single human stem cell-derived cardiomyocytes. Stem Cell Rep. 5, 1226–1238 (2015). · DOI · Paper page
  10. Liau, B., Christoforou, N., Leong, K. W. & Bursac, N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 32, 9180–9187 (2011). · DOI · Paper page
  11. Ribeiro, A. J. et al. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness. Proc. Natl Acad. Sci. USA 112, 12705–12710 (2015). · DOI · Paper page
  12. Hinson, J. T. et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349, 982–986 (2015). · DOI · Paper page
  13. Stoppel, W. L., Kaplan, D. L. & Black, L. D.III Electrical and mechanical stimulation of cardiac cells and tissue constructs. Adv. Drug Deliv. Rev. 96, 135–155 (2016). · DOI · Paper page
  14. Klein, F. et al. Elastic fully three-dimensional microstructure scaffolds for cell force measurements. Adv. Mater. 22, 868–871 (2010). · DOI · Paper page
  15. Jeon, H., Hidai, H., Hwang, D. J. & Grigoropoulos, C. P. Fabrication of arbitrary polymer patterns for cell study by two-photon polymerization process. J. Biomed. Mater. Res. A 93, 56–66 (2010). · DOI
  16. Ma, Z. et al. Three-dimensional filamentous human diseased cardiac tissue model. Biomaterials 35, 1367–1377 (2014). · DOI · Paper page
  17. Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127–137 (2013). · DOI · Paper page
  18. Thavandiran, N. et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl Acad. Sci. USA 110, E4698–E4707 (2013). · DOI · Paper page
  19. Huebsch, N. et al. Miniaturized iPS-cell-derived cardiac muscles for physiologically relevant drug response analyses. Sci. Rep. 6, 24726 (2016). · DOI · Paper page
  20. Gautel, M., Furst, D. O., Cocco, A. & Schiaffino, S. Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. Circ. Res. 82, 124–129 (1998). · DOI
  21. Bennett, P. M., Furst, D. O. & Gautel, M. The C-protein (myosin binding protein C) family: regulators of contraction and sarcomere formation? Rev. Physiol. Biochem. Pharmacol. 138, 203–234 (1999). · DOI
  22. Moss, R. L., Fitzsimons, D. P. & Ralphe, J. C. Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium. Circ. Res. 116, 183–192 (2015). · DOI
  23. Previs, M. J. et al. Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science 337, 1215–1218 (2012). · DOI · Paper page
  24. Lan, F. et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12, 101–113 (2013). · DOI · Paper page
  25. Argenziano, M. et al. Electrophysiologic characterization of calcium handling in human induced pluripotent stem cell-derived atrial cardiomyocytes. Stem Cell Rep. 10, 1867–1878 (2018). · DOI · Paper page
  26. Hidai, H., Jeon, H., Hwang, D. J. & Grigoropoulos, C. P. Self-standing aligned fiber scaffold fabrication by two photon photopolymerization. Biomed. Microdevices 11, 643–652 (2009). · DOI
  27. Musunuru, K. Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis. Models Mech. 6, 896–904 (2013). · DOI
  28. Harris, S. P. et al. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ. Res. 90, 594–601 (2002). · DOI · Paper page
  29. Korte, F. S., McDonald, K. S., Harris, S. P. & Moss, R. L. Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C. Circ. Res. 93, 752–758 (2003). · DOI · Paper page
  30. De Lange, W. J. et al. Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circ. Res. 109, 8–19 (2011). · DOI · Paper page
  31. Fraysse, B. et al. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J. Mol. Cell. Cardiol. 52, 1299–1307 (2012). · DOI
  32. Chen, P. P. et al. Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice. Circulation 126, 1194–1205 (2012). · DOI
  33. Baumgarten, G. et al. Myocardial injury modulates the innate immune system and changes myocardial sensitivity. Basic Res. Cardiol. 101, 427–435 (2006). · DOI
  34. Birket, M. J. et al. Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function. Cell Rep. 13, 733–745 (2015). · DOI · Paper page
  35. Ribeiro, A. J. S. et al. Multi-imaging method to assay the contractile mechanical output of micropatterned human iPSC-derived cardiac myocytes. Circ. Res. 120, 1572–1583 (2017). · DOI
  36. Yang, H. et al. Dynamic myofibrillar remodeling in live cardiomyocytes under static stretch. Sci. Rep. 6, 20674 (2016). · DOI
  37. Hirt, M. N. et al. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology. J. Mol. Cell. Cardiol. 81, 1–9 (2015). · DOI
  38. Stohr, A. et al. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. J. Mol. Cell. Cardiol. 63, 189–198 (2013). · DOI · Paper page
  39. Tanaka, A. et al. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J. Am. Heart Assoc. 3, e001263 (2014). · DOI · Paper page
  40. Wei, J. Q. et al. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118, 934–946 (2008). · DOI · Paper page
  41. He, A., Kong, S. W., Ma, Q. & Pu, W. T. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl Acad. Sci. USA 108, 5632–5637 (2011). · DOI · Paper page
  42. He, A. et al. Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease. Nat. Commun. 5, 4907 (2014). · DOI · Paper page
  43. Dai, Y. S., Cserjesi, P., Markham, B. E. & Molkentin, J. D. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. J. Biol. Chem. 277, 24390–24398 (2002). · DOI · Paper page
  44. Sunagawa, Y. et al. Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes. J. Biol. Chem. 285, 9556–9568 (2010). · DOI
  45. Hutter, J. L. & Bechhoefer, J. Calibration of atomic-force microscope tips. Rev. Sci. Instrum. 64, 1868–1873 (1993). · DOI · Paper page
  46. Laughner, J. I. et al. Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. Am. J. Physiol. Heart C 303, H753–H765 (2012). · DOI · Paper page

Cited by

See all 109

Metadata

Authors
Ma, Z., Huebsch, N., Koo, S., Mandegar, M. A., Siemons, B., Boggess, S., Conklin, B. R., Grigoropoulos, C. P., & Healy, K. E.
Venue
Nature Biomedical Engineering
Published
2018-09-10
Volume
2
Issue
12
Pages
955-967
ISSN
2157-846X (ISSN-L)
OpenAlex
W2889316118
Cited by
109
References
10
FWCI
9.46
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload. https://app.cochat.ai/papers/10.1038/s41551-018-0280-4
The paper
Ma, Z., Huebsch, N., Koo, S., Mandegar, M. A., Siemons, B., Boggess, S., Conklin, B. R., Grigoropoulos, C. P., & Healy, K. E. (2018). Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-018-0280-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.